Antiparasitics

Customized

Antiparasitics

Antiparasitic APIs include antihelminthic, antiprotozoal, and antiparasitic ectoparasite agents. They are used in treating parasitic infections such as malaria, filariasis, schistosomiasis, amoebiasis, and tapeworm diseases. These APIs are critical in global public health, veterinary medicine, and tropical disease management, requiring high efficacy and safety.

Antiprotozoal Drugs

Antiprotozoal drugs are active pharmaceutical ingredients designed to treat infections caused by protozoan parasites such as Giardia, Trypanosoma, Toxoplasma, Leishmania, and Plasmodium species. These APIs act through diverse mechanisms, including inhibition of nucleic acid synthesis, disruption of mitochondrial function, interference with folate pathways, or generation of reactive intermediates that damage parasitic DNA and proteins. Antiprotozoal agents encompass nitroimidazoles, antimalarial compounds, antimonial drugs, diamidines, and novel targeted molecules developed to address increasing drug resistance. They are used for acute and chronic infections affecting the gastrointestinal tract, bloodstream, central nervous system, and visceral organs. Pharmaceutical formulations include tablets, suspensions, injectables, and fixed-dose combinations tailored for global health needs. Antiprotozoal drugs play a vital role in reducing morbidity, preventing severe complications, and supporting control programs for major tropical diseases. Ongoing research continues to expand therapeutic options, improve safety profiles, and overcome resistance in protozoan pathogens.

Fumagillin CAS NO 23110-15-8

Unit Price:Get Price

CAS No.:23110-15-8

Grade:Pharmacy Grade

Content:99.00%

Packaging:Customizable

Robenidine Hydrochloride CAS NO 25875-50-7

Unit Price:Get Price

CAS No.:25875-50-7

Grade:Pharmacy Grade

Content:99.00%

Packaging:Customizable

Clopidol CAS NO 2971-90-6

Unit Price:Get Price

CAS No.:2971-90-6

Grade:Pharmacy Grade

Content:99.00%

Packaging:Customizable

Ronidazole CAS NO 7681-76-7

Unit Price:Get Price

CAS No.:7681-76-7

Grade:Pharmacy Grade

Content:99.00%

Packaging:Customizable

Pentamidine CAS NO 100-33-4

Unit Price:Get Price

CAS No.:100-33-4

Grade:Pharmacy Grade

Content:99.0%

Packaging:Customizable

Pentanamidine CAS NO 109-51-3

Unit Price:Get Price

CAS No.:109-51-3

Grade:Pharmacy Grade

Content:99.0%

Packaging:Customizable

Amprolium CAS NO 121-25-5

Unit Price:Get Price

CAS No.:121-25-5

Grade:Pharmacy Grade

Content:99.0%

Packaging:Customizable

Stilbamidine CAS NO 122-06-5

Unit Price:Get Price

CAS No.:122-06-5

Grade:Pharmacy Grade

Content:99.0%

Packaging:Customizable

Anthelmintics

Anthelmintics are active pharmaceutical ingredients designed to eliminate helminths, including nematodes, cestodes, and trematodes, through targeted disruption of their neuromuscular, metabolic, or structural systems. These APIs include benzimidazoles, macrocyclic lactones, nicotinic receptor agonists, and praziquantel-based compounds, each acting on specific molecular pathways that impair parasite survival. Their mechanisms involve inhibiting microtubule polymerization, blocking glucose uptake, inducing sustained neuromuscular paralysis, or altering calcium homeostasis within the parasite. Anthelmintics are essential for treating intestinal and systemic worm infections, improving nutritional outcomes, reducing parasite transmission, and preventing long-term organ damage. They are widely used in human and veterinary medicine and formulated as tablets, chewables, suspensions, and extended-release preparations. Due to rising anthelmintic resistance, ongoing research focuses on combination therapies, new molecular targets, and optimized dosing strategies. Anthelmintics remain a cornerstone of parasitic disease control and global public health.